Rapid Voice News

British biotech firm Immunocore picks Nasdaq for $100m IPO – The Times

One of Britains most promising biotech companies has opted to float in New York rather than London in a blow for the stock exchange.
Immunocore is looking to raise up to $100 million through an init… [+564 chars]